Identification of antiviral secondary metabolites from sweet lemon grass, Cymbopogon nardus (L.) Rendle, inhibiting measles virus
An in vitro study was carried out to investigate the antiviral effects of sweet lemon grass (Cymbopogon nardus (L.) Rendle) on measles virus (MV). Crude extract of this plant were prepared using hexane and fractionation of this extract was done using column chromatography (CC). First CC produced...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/8797/4/MARDZIAH%20BINTI%20MANAS%20%28fulltext%29.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | An in vitro study was carried out to investigate the antiviral effects of sweet lemon grass
(Cymbopogon nardus (L.) Rendle) on measles virus (MV). Crude extract of this plant were
prepared using hexane and fractionation of this extract was done using column chromatography
(CC). First CC produced a total of 20 combined fractions and further fractionation on selected
fractions resulted in 77 combined subfractions. The toxicity of all fractions and subfractions
towards Vero cells ranged from mildly toxic (50 μg/ml) to considerably non-toxic (600 μg/ml). In
the antiviral test, majority of the fractions inhibited the production of MV-induced cytopathic
effects (CPE) by more than 50%. Some of them were able to inhibit the CPE by more than 75%,
which was similar to the activity showed by positive control, Ribavirin, which is 80%. Most of
the subfractions conferred around 50% of protection to the cells, but majority of them had lower
antiviral activity compared to their derived fractions.In an attempt to study the mode of antiviral
action, pre-treatment and post-infection protocols were used. It was found that post-infection
protocol was more effective among fractions, suggesting that the fractions may interfere with any
of the steps in late stage of MV replication. However, the subfractions did not give any particular
trend as to the most effective method of treatment. Active subfractions were then further purified
using preparative thin layer chromatography (PTLC) and produced 11 isolated compounds. These
compounds possess weak antiviral activity with majority of them inhibited less than 50% of virus
CPE. Most of isolated compounds provided better protection to the cells in the pre-treatment protocol, suggesting that the potential sites of activity may include inhibition of virus binding
and/or entry which can be mediated by a number of cellular receptors such as CD46 present on
Vero cells. Meanwhile for the synergistic assay, the combination of Ribavirin with isolated
compounds at lowest concentration (0.01 LC50) produced synergistic effect, either in one or both
protocol. The clear synergistic tendencies displayed by these substances combination allows for
the reduction of Ribavirin concentration, which minimizes toxicity and the probability of
formation of resistance to this drug. This synergistic activity is probably connected to the
different mechanisms of action of Ribavirin and isolated compound. Additional test, antiproliferation
assay, showed that the isolated compounds possess weak activity towards human
papillary ovarian adenocarcinoma (Caov-3) cancer cells as they were able to inhibit less than
50% of the cells growth at highest concentration tested. Result also showed that they were toxic
to normal cells as their cytotoxic values on cancer cells (>400 μg/ml) were much higher than that
of the normal cells (150 to 270 μg/ml) and the reference drug, Tamoxifen (150 μg/ml). The GCMS
analysis revealed that majority of the active isolated compounds had more than one
constituent that were accounted for their inhibitory activity. The constituents are made up of
monoterpene, sesquiterpene and hydrocarbon that present commonly in the essential oil of C.
nardus, such as methyl eugenol, citronellol and geraniol. |
|---|